UPDATE: Citi Upgrades Zymeworks (ZYME) to Buy, 'Better Risk/Reward Has Emerged'

Go back to UPDATE: Citi Upgrades Zymeworks (ZYME) to Buy, 'Better Risk/Reward Has Emerged'

Zymeworks (ZYME) PT Lowered to $38 at Barclays

January 28, 2021 5:35 AM EST

Barclays lowered its price target on Zymeworks (NYSE: ZYME) to $38.00 (from $47.00) while maintaining a Equalweight rating.... More